NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-244-2015-0-CN-05 Brachyury Deletion Mutants, Non-Yeast Vectors Encoding Brachyury Deletion Mutants, and Their Use CN National Stage 201680057188.0 Issued
NCATS E-060-2017-3-US-02 Compositions And Methods For Identifying And Treating Dystonia Disorders US National Stage 15/764,320 11285142 Issued PDF
NCATS E-257-2010-0-EP-18 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EP DIV 18165005.2 Issued
NCATS E-257-2010-0-GB-56 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GB EP 18165005.2 Issued
NCATS E-257-2010-0-BG-48 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators BG EP 18165005.2 Issued
NCATS E-257-2010-0-HR-72 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators HR EP 18165005.2 Issued
NCATS E-257-2010-0-CZ-50 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CZ EP 18165005.2 Issued
NCATS E-257-2010-0-CY-70 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CY EP 18165005.2 Issued
NCATS E-257-2010-0-SK-68 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SK EP 18165005.2 Issued
NCATS E-257-2010-0-NO-63 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NO EP 18165005.2 Issued
NCATS E-257-2010-0-RO-66 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators RO EP 18165005.2 Issued
NCATS E-257-2010-0-MT-77 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators MT EP 18165005.2 Issued
NCATS E-257-2010-0-PL-64 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PL EP 18165005.2 Issued
NCATS E-257-2010-0-SI-79 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SI EP 18165005.2 Issued
NCATS E-257-2010-0-PT-65 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators PT EP 18165005.2 Issued
NCATS E-257-2010-0-NL-62 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators NL EP 18165005.2 Issued
NCATS E-257-2010-0-RS-78 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators RS EP 18165005.2 Issued
NCATS E-257-2010-0-IT-60 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IT EP 18165005.2 Issued
NCATS E-257-2010-0-LU-75 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LU EP 18165005.2 Issued
NCATS E-257-2010-0-LT-74 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LT EP 18165005.2 Issued
NCATS E-257-2010-0-LI-61 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LI EP 18165005.2 Issued
NCATS E-257-2010-0-LV-76 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators LV EP 18165005.2 Issued
NCATS E-257-2010-0-AT-46 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators AT EP 18165005.2 Issued
NCATS E-257-2010-0-BE-47 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators BE EP 18165005.2 Issued
NCATS E-257-2010-0-ES-53 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators ES EP 18165005.2 Issued
NCATS E-257-2010-0-CH-49 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators CH EP 18165005.2 Issued
NCATS E-257-2010-0-SE-67 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators SE EP 18165005.2 Issued
NCATS E-257-2010-0-TR-69 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators TR EP 18165005.2 Issued
NCATS E-257-2010-0-FI-54 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators FI EP 18165005.2 Issued
NCATS E-257-2010-0-FR-55 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators FR EP 18165005.2 Issued
NCATS E-257-2010-0-EE-71 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators EE EP 18165005.2 Issued
NCATS E-257-2010-0-DK-52 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators DK EP 18165005.2 Issued
NCATS E-257-2010-0-IE-59 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IE EP 18165005.2 Issued
NCATS E-257-2010-0-IS-73 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators IS EP 18165005.2 Issued
NCATS E-257-2010-0-DE-51 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators DE EP 18165005.2 Issued
NCATS E-257-2010-0-GR-57 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators GR EP 18165005.2 Issued
NCATS E-257-2010-0-HU-58 Substituted Pyrazolopyrimidines as Glucocerebrosidase Activators HU EP 18165005.2 Issued
NIAID E-102-2018-0-PCT-02 Antibody-mediated Conditioning With Immunosuppression To Enable Allogeneic Transplantation PCT PCT PCT/US2018/025044 Expired
NINDS E-024-2016-1-US-03 METHODS OF TREATING AND PREVENTING AMYOTROPHIC LATERAL SCLEROSIS US National Stage 15/764,647 Abandoned
NCATS E-252-2017-0-US-01 METHOD OF TREATMENT OF CANCER CELLS EXHIBITING TRAIL RESISTANCE US 62/650,147 Abandoned
NCI E-105-2018-0-US-01 Biomarker Analysis Software For High-Throughput Diagnostic Multiplex Data US 62/650,162 Abandoned
NCI E-067-2017-0-CA-04 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES CA National Stage 3057375 Issued
NCI E-208-2015-0-US-07 THALIDOMIDE ANALOGS AND METHODS OF USE US National Stage 15/764,193 10730835 Issued PDF
NIAID E-099-2016-0-US-03 Use Of Roseomonas Species To Treat Eczematous Skin Disease US National Stage 15/939,066 10195236 Issued PDF
NCI E-067-2017-0-PCT-02 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES PCT PCT PCT/US2018/024828 Expired
NIAID E-256-2015-2-GB-12 Modified Anthrax Toxin Protective Antigen GB EP 16767065.2 Issued
NIAID E-256-2015-2-EP-05 Modified Anthrax Toxin Protective Antigen EP National Stage 16767065.2 Issued
NIAID E-256-2015-2-DE-10 Modified Anthrax Toxin Protective Antigen DE EP 16767065.2 Issued
NIAID E-256-2015-2-FR-11 Modified Anthrax Toxin Protective Antigen FR EP 16767065.2 Issued
NIAID E-083-2017-0-FR-01 GLYCAN-MASKED ENGINEERED OUTER DOMAINS OF HIV-1 GP120 AND THEIR USE FR EP 18721513.2 Issued